Data / Form D filings / Retrotope, Inc.
Retrotope, Inc.: Form D filings
Retrotope, Inc., a biotechnology company in Los Altos, CA, filed 17 Form D notices with the SEC between 2014 and 2021. The latest, on May 13, 2021, reports $25.5 million sold of a $58.3 million offering to 39 investors.
Find out what Retrotope, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4300 EL CAMINO REAL, SUITE 201, Los Altos, CA, 94022
- Phone
- (650) 917-9256
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1607677
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2021 | Amendment | $58,298,500 | $25,537,307 | $32,761,193 | 39 | Aug 14, 2020 | sec.gov |
| Jan 15, 2021 | Amendment | $50,000,000 | $13,298,500 | $36,701,500 | 25 | Aug 14, 2020 | sec.gov |
| Dec 15, 2020 | Amendment | $50,000,000 | $12,887,000 | $37,113,000 | 21 | Aug 14, 2020 | sec.gov |
| Aug 28, 2020 | New notice | $50,000,000 | $10,100,000 | $39,900,000 | 3 | Aug 14, 2020 | sec.gov |
| Jul 30, 2019 | New notice | $4,067,933 | $4,067,933 | $0 | 28 | Jul 17, 2019 | sec.gov |
| Jul 12, 2019 | Amendment | $20,900,000 | $20,000,000 | $900,000 | 37 | Nov 30, 2018 | sec.gov |
| May 15, 2019 | Amendment | $20,900,000 | $8,049,264 | $12,850,736 | 20 | Nov 30, 2018 | sec.gov |
| Feb 27, 2019 | Amendment | $20,900,000 | $5,234,265 | $15,665,735 | 14 | Nov 30, 2018 | sec.gov |
| Dec 13, 2018 | New notice | $20,900,000 | $3,000,000 | $17,900,000 | 1 | Nov 30, 2018 | sec.gov |
| Dec 13, 2018 | New notice | $4,330,506 | $4,330,506 | $0 | 40 | Nov 30, 2018 | sec.gov |
| Jan 3, 2018 | New notice | $3,000,000 | $2,350,000 | $650,000 | 16 | Dec 21, 2017 | sec.gov |
| Nov 29, 2016 | New notice | $10,000,000 | $2,727,869 | $7,272,131 | 26 | Nov 14, 2016 | sec.gov |
| Mar 25, 2016 | Amendment | $20,000,000 | $14,532,456 | $5,467,544 | 66 | May 9, 2014 | sec.gov |
| Jan 20, 2015 | Amendment | $10,000,000 | $9,955,500 | $44,500 | 46 | May 9, 2014 | sec.gov |
| Oct 22, 2014 | Amendment | $10,000,000 | $9,799,000 | $201,000 | 43 | May 9, 2014 | sec.gov |
| Aug 19, 2014 | Amendment | $10,000,000 | $6,329,000 | $3,671,000 | 28 | May 9, 2014 | sec.gov |
| May 21, 2014 | New notice | $10,000,000 | $5,809,000 | $4,191,000 | 24 | May 9, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George Garibaldi | Director | |
| Nitin Mehta | Director | |
| Mikhail Shchepinov | Executive Officer, Director | |
| Corey McCann | Director | |
| Yvonne Kao | Executive Officer | |
| Anil Kumar | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of May 10, 2021 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Retrotope, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.